Australia vs Tonga: Cause of death, by non-communicable diseases, ages 60+, male
Australia
91.6%
in 2021
Tonga
90.4%
in 2021
Australia rank
5th
Tonga rank
7th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Australia
- Tonga
How they compare
Australia currently reports 91.6% against 90.4% in Tonga, a difference of 1.2%.
Across all 6 years both countries report, Australia has been ahead every year.
Australia ranks 5th and Tonga ranks 7th of 185 countries.
Australia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.9% | 89.7% | 4.2% | Australia |
| 2010s | 92.4% | 90.3% | 2.1% | Australia |
| 2020s | 91.7% | 90.4% | 1.3% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Australia or Tonga?
- Australia, at 91.6% against 90.4% in Tonga as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Australia and Tonga?
- 1.2%, with Australia ahead.
- How many years of comparable data are there for Australia and Tonga?
- 6 years are reported by both, from 2000 to 2021.
- How do Australia and Tonga rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Australia ranks 5th and Tonga ranks 7th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.